image dons

je fais un don

2019 ESC/EAS Guidelines for management of dyslipidaemia : strengths and limitations

Publié dans European Heart Journal Cardiovascular Pharmacotherapy 2020 Jul 11 :pvaa077

Auteurs : Zeitouni M, Sabouret P, Kerneis M, Silvain J, Collet JP, Bruckert E, Montalescot G.

Article disponible en consultant le site

Abstract

European Heart Journal - Cardiovascular Pharmacotherapy

In 2019, the European Society of Cardiology and European Atherosclerosis Society released a new guideline document with substantial changes regarding the assessment of cardiovascular risk and treatments. The update of high-risk criteria and categories led to a better detection and primary prevention of patients at risk of a first cardiovascular event. Nonetheless, additional efforts are needed for a better inclusion of risk modifiers, especially specific to women, to improve risk stratification and direct primary prevention. Eventually, we discuss how these new guidelines implement PCSK9 inhibitors for very-high risk individuals and the evidence supporting new LDL-C goals below such as 55 mg/dL and 40 mg/dL. […]

Autres actualités

+

10/09/2020


Culprit lesion location and outcomes in patients with multi-...

Publié dans EuroIntervention 2020 Sep 8: EIJ-D-20-00561. Auteurs : Hauguel-Moreau M, Barthélémy O, Farhan...
+

01/09/2020


COVID-19 acute myocarditis and Multisystem Inflammatory Synd...

Publié dans Chest 2020 Sep 7: S0012-3692(20)34359-2 Auteurs : Hékimian G, Kerneis M, Zeitouni M, Cohen-Au...
+

01/08/2020


Interleukin-1Beta and Risk of Premature Death in Patients wi...

Publié dans Journal of the American College of Cardiology 2020 Aug 19 :S0735-1097(20)36323-3 Auteurs : Si...